The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 5, 2003, Pages 1292-1296

  Pan, Charlie C ^a,b   Lee, Julia S ^a   Chan, June L ^a   Sandler, Howard M ^a   Underwood, Willie ^b   McLaughlin, Patrick W ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Community hospital; Prostate cancer; PSA; Race; University hospital

Indexed keywords

ANTIGENS; BIOMEDICAL ENGINEERING; DISEASE CONTROL; ECONOMIC AND SOCIAL EFFECTS; RADIOTHERAPY;

DEMOGRAPHIC ANALYSIS;

ONCOLOGY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; COMMUNITY CARE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE; UNIVERSITY HOSPITAL;

EID: 0344395015     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00771-5     Document Type: Article

References (11)

1. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin. 53:2003;5-26.
2. Moul J.W., Sesterhenn I.A., Connelly R.R., et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 274:1995;1277-1281.
3. Vijayakumar S., Winter K., Sause W., et al. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study Results of RTOG 94-12 . Int J Radiat Oncol Biol Phys. 40:1998;17-25.
4. Asbell S.O., Vijayakumar S. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Prostate. 31:1997;42-46.
5. Jani A.B., Vaida F., Hanks G., et al. Changing face and different countenances of prostate cancer Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era . Int J Cancer. 96:2001;363-371.
6. von Eschenbach A., Ho R., Murphy G.P., et al. American Cancer Society guidelines for the early detection of prostate cancer Update, June 10, 1997 . Cancer. 80:1997;1805-1807.
7. Vijayakumar S., Karrison T., Weichselbaum R.R., et al. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol Biomarkers Prev. 1:1992;541-545.
8. Vijayakumar S., Weichselbaum R., Vaida F., et al. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J Sci Am. 2:1996;225.
9. Moul J.W., Connelly R.R., Mooneyhan R.M., et al. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. J Urol. 162:1999;394-397.
10. Vijayakumar S., Vaida F., Weichselbaum R., et al. Race and the Will Rogers phenomenon in prostate cancer. Cancer J Sci Am. 4:1998;27-34.
11. Wei JT. Survey of men newly diagnosed with prostate cancer: The Michigan Cancer Consortium priority objective. American Urological Association. Chicago, IL; 2002.